Evidence map›Paper›PMID 33280258›Full record

ArticleThe Kaohsiung journal of medical sciences2021

Decreased drug resistance of bladder cancer using phytochemicals treatment.

Chun-Jung Cho, Cheng-Ping Yu, Chia-Lun Wu, Jar-Yi Ho, Ching-Wei Yang, Dah-Shyong Yu

Open access · goldAbstract read
In one paragraph

Article in The Kaohsiung journal of medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Focus on the Use of Resveratrol in Bladder Cancer.International journal of molecular sciences · 2023
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Resveratrol effects in bladder cancer: A mini review.Genetics and molecular biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chun-Jung ChoGraduate Institute of Pathology and Parasitology, National Defense Medical Center, Taipei, R.O.C.
Cheng-Ping YuGraduate Institute of Pathology and Parasitology, National Defense Medical Center, Taipei, R.O.C.
Chia-Lun WuDivision of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, R.O.C.
Jar-Yi HoGraduate Institute of Pathology and Parasitology, National Defense Medical Center, Taipei, R.O.C.
Ching-Wei YangDepartment of Urology, Cheng-Hsin General Hospital, Taipei, R.O.C.
Dah-Shyong YuDivision of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, R.O.C.ORCID https://orcid.org/0000-0001-7594-0070
National Defense Medical Center · TWCheng Hsin General Hospital · TW

Funding

Cheng Hsin general hospital -106-06Cheng Hsin general hospital CH-NDMC-105-7Ministry of Science and Technology, Republic of China MOST-104-2314-B-016-040-MY3Ministry of Science and Technology, Republic of China MOST-106-2320-B-016 -013 -MY3National Defense Medical Center MAB-109-064Tri-Service General Hospital TSGH-C106-045Tri-Service General Hospital TSGH-D-109093
6 · The paper itself

Abstract

The aim of the study is to investigate the ability of phytochemicals to overcome the multiple drug resistance (MDR) of bladder cancer. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to evaluate the cytotoxic sensitivity of T24-GCB cells, a GCB resistant cell line, to different phytochemicals, including capsaicin, quercetin, curcumin, and resveratrol, and their combination with gemcitabine. Western blot analysis was used to detect the expression of membranous ABCC2 and metabolic proteins, DCK, TK1, and TK2 in tumor cells. Animal models were used to confirm the treatment efficacy of phytochemicals in combination with gemcitabine to bladder cancer. The observed/expected ratio of cytotoxicity analysis revealed that capsaicin has synergistic effect with gemcitabine to T24-GCB cells in a dose-dependent pattern. Quercetin, curcumin, and resveratrol have additive effect with gemcitabine to T24-GCB cells. Capsaicin and quercetin alone and combination with gemcitabine decreased the expression of ABCC2 and DCK and TKs, in T24-GCB cells. On the contrary, resveratrol and curcumin alone and combination with gemcitabine increased the expression of ABCC2 but decreased cytoplasmic kinases simultaneously. In xenografted subcutaneous tumor model on nude mice, combination treatment of capsaicin and gemcitabine demonstrated the highest tumor suppression effect when compared to capsaicin or gemcitabine treatment alone. The MDR of bladder cancer is closely related to membranous ABCC2, cytoplasmic DCK, and TKs expression. Capsaicin owns the strongest synergistic cytotoxic effect of gemcitabine to T24-GCB cells. This combination regimen may provide as an adjunctive treatment for overcoming MDR in bladder cancer.

Indexed as

Drug Resistance, NeoplasmAnimalsAntineoplastic AgentsCell DeathCell Line, TumorCell SurvivalDeoxycytidineDrug Resistance, MultipleFemaleGemcitabineHumansMiceMice, Inbred BALB CMice, NudeMultidrug Resistance-Associated Protein 2PhytochemicalsABCC2 protein, humanAntineoplastic AgentsDeoxycytidineGemcitabineMultidrug Resistance-Associated Protein 2PhytochemicalsABCC2 proteinbladder cancercapsaicingemcitabine resistancephytochemicals

Identifiers

PMID33280258
PMCPMC11896564
OpenAlexW3112492193

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.